NCT07616128Phase 2Recruiting

Study of EVO756 in Adults With Migraine

Study sponsor: Evommune, Inc. · EVMN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-10Estimated
Enrollment · participants330Estimated
Source updated2026-11-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source